8-KRegulation FDExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Regulation FD Disclosure (Nov 16, 2021)

Filed November 16, 2021For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on November 16, 2021, to announce the posting of an investor presentation to their website. This presentation, dated November 16, 2021, is provided as Exhibit 99.1 to the filing. While the 8-K itself doesn't contain new financial data or material business updates, the investor presentation is the primary focus for investors seeking the latest information and strategic outlook from the company. Investors should review this presentation to understand BMY's current messaging on its business, pipeline, and financial performance. It's important to note that the information furnished in this 8-K, including the investor presentation, is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as a formally filed document regarding misstatements or omissions. However, it serves as a key communication channel for the company to disseminate information to its investors.

Key Highlights

  • 1BMY released an investor presentation on November 16, 2021.
  • 2The investor presentation is accessible via BMY's investor relations website.
  • 3The presentation is attached as Exhibit 99.1 to the Form 8-K filing.
  • 4The filing serves as a disclosure vehicle for the investor presentation.
  • 5The information provided is not considered "filed" under Section 18 of the Exchange Act.
  • 6Investors should refer to the investor presentation for the most current company information and strategic insights.

Frequently Asked Questions